AAAAAA

   
Results: 1-7 |
Results: 7

Authors: McDougle, CJ Scahill, L McCracken, JT Aman, MG Tierney, E Arnold, LE Freeman, BJ Martin, A McGough, JJ Cronin, P Posey, DJ Riddle, MA Ritz, L Swiezy, NB Vitiello, B Volkmar, FR Votolato, NA Walson, P
Citation: Cj. Mcdougle et al., Research Units on Pediatric Psychopharmacology (RUPP) autism network - Background and rationale for an initial controlled study of risperidone, CH ADOLESC, 9(1), 2000, pp. 201

Authors: Aman, MG Collier-Crespin, A Lindsay, RL
Citation: Mg. Aman et al., Pharmacotherapy of disorders in mental retardation, EUR CHILD A, 9, 2000, pp. 98-107

Authors: Aman, MG Langworthy, KS
Citation: Mg. Aman et Ks. Langworthy, Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders, J AUTISM D, 30(5), 2000, pp. 451-459

Authors: Arnold, LE Aman, MG Martin, A Collier-Crespin, A Vitiello, B Tierney, E Asarnow, R Bell-Bradshaw, F Freeman, PJ Gates-Ulanet, P Klin, A McCracken, JT McDougle, CJ McGough, JJ Posey, DJ Scahill, L Swiezy, NB Ritz, L Volkmar, F
Citation: Le. Arnold et al., Assessment in multisite randomized clinical trials of patients with autistic disorder: The autism RUPP network, J AUTISM D, 30(2), 2000, pp. 99-111

Authors: Aman, MG Armstrong, SA
Citation: Mg. Aman et Sa. Armstrong, Regarding secretin for treating autistic disorder, J AUTISM D, 30(1), 2000, pp. 71-72

Authors: Aman, MG Madrid, A
Citation: Mg. Aman et A. Madrid, Atypical antipsychotics in persons with developmental disabilities, MENT RET D, 5(4), 1999, pp. 253-263

Authors: Aman, MG Arnold, LE Armstrong, SC
Citation: Mg. Aman et al., Review of serotonergic agents and perseverative behavior in patients with developmental disabilities, MENT RET D, 5(4), 1999, pp. 279-289
Risultati: 1-7 |